Government urged to promote domestic pharmaceutical firms' R&D efforts

Published: 2007-04-11 07:00:00

Updated: 2007-04-11 07:00:00

Following the clinching of a free trade agreement (FTA) with the United States, major pharmaceutical firms in Korea have called for the government to work out measures to support their research and development projects for new drugs and minimize possible damage to the industry from the FTA.

We...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK